Amyloidosis Foundation
Amyloidosis Foundation maintains stable finances and zero reported officer compensation over a decade.
EIN: 200291856 · Clarkston, MI · NTEE: H25 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $1.0M |
| Total Expenses | $569K |
| Program Spending | 85% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $1.0M |
| Transparency Score | 90/100 |
Search Intent Cockpit
Amyloidosis Foundation Form 990, Revenue, CEO Pay, and IRS Filing Signals
Amyloidosis Foundation is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Amyloidosis Foundation in one place.
Form 990 Filing Summary
14 filing years are available, with latest revenue of $535K and expenses of $569K.
Revenue and Expenses
Amyloidosis Foundation reported $535K in revenue and $569K in expenses, a deficit of $34K.
Executive Compensation
Top officer compensation appears as $1 in the stored analysis, with context against revenue and expenses below.
Charity Score and Red Flags
90/100 mission score, 1 red flag, and 4 strengths are shown from structured and AI review.
Is Amyloidosis Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $484K (85%) |
Across stored filings, Amyloidosis Foundation shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Some Concerns | Good filing record; 1 red flag identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade B | 14 stored filing years |
| Peer context | Compare with American Academy Of Podiatric Practice Management | Michigan and Category H context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with American Academy Of Podiatric Practice Management →All Michigan nonprofits
All Category H
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Clarkston, MI nonprofitsCategory H in Michigan
Health in Michigan
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category H spending
Best Category H charities in Michigan
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Personal Assistance Options
Midland, MI · $3.3M revenue · Score 92/100
Compare side-by-sideNew Level Sports
Battle Creek, MI · $1.5M revenue · Score 92/100
Compare side-by-sideSecond Impressions
Kalamazoo, MI · $915K revenue · Score 90/100
Compare side-by-sideRadclift Inc
Oak Park, MI · $1.0M revenue · Score 88/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Amyloidosis Foundation directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Amyloidosis Foundation
Amyloidosis Foundation (EIN: 200291856) is a nonprofit organization based in Clarkston, MI, classified under NTEE code H25. The organization reported total revenue of $1.0M and total assets of $1.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Amyloidosis Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Amyloidosis Foundation is a mid-size nonprofit that has been operating for 21 years, with 14 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 1.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $535K |
| Total Expenses | $569K |
| Surplus / Deficit | $-33,758 |
| Total Assets | $1.1M |
| Total Liabilities | $5K |
| Net Assets | $1.0M |
| Operating Margin | -6.3% |
| Debt-to-Asset Ratio | 0.4% |
| Months of Reserves | 22.2 months |
Financial Health Grade: B
In 2023, Amyloidosis Foundation reported a deficit of $34K with expenses exceeding revenue, holds 22.2 months of operating reserves (strong position), has a debt-to-asset ratio of 0.4% (very low leverage).
Financial Trends
Over 14 years of filings (2010–2023), Amyloidosis Foundation's revenue has grown at a compound annual growth rate (CAGR) of 1.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -24.7% | -4.9% | -0.5% |
| 2022 | -8.8% | -15.7% | -0.4% |
| 2021 | +12.3% | +19.9% | +11.5% |
| 2020 | -5.9% | -13.6% | +25.7% |
| 2019 | +11.6% | +9.5% | +13.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1280 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Amyloidosis Foundation with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Amyloidosis Foundation allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $34K, with expenses exceeding revenue.
- Debt-to-asset ratio: 0.4%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's leadership is either entirely volunteer-based or compensated through non-officer roles, which is highly efficient for an organization with over $1 million in assets.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Amyloidosis Foundation's IRS 990 filings:
- Fluctuating annual revenue, with a notable decrease from $779,248 in 2021 to $535,162 in 2023, could indicate potential challenges in consistent fundraising or donor retention.
Strengths
The following positive indicators were identified for Amyloidosis Foundation:
- Zero reported officer compensation across all 14 filings, indicating highly efficient use of funds.
- Consistent growth in assets, from $612,000 in 2016 to over $1 million in recent years, demonstrating strong financial management and reserve building.
- Low liabilities relative to assets, indicating a healthy balance sheet and minimal debt.
- Long history of consistent IRS 990 filings (14 filings), demonstrating strong transparency and accountability.
Frequently Asked Questions about Amyloidosis Foundation
Is Amyloidosis Foundation a legitimate charity?
Amyloidosis Foundation (EIN: 200291856) is a registered tax-exempt nonprofit based in Michigan. Our AI analysis gives it a Mission Score of 90/100. It has 14 years of IRS 990 filings on record. Total revenue: $1.0M. 1 red flag identified. 4 strengths noted. Financial health grade: B.
How does Amyloidosis Foundation spend its money?
Amyloidosis Foundation directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Amyloidosis Foundation tax-deductible?
Amyloidosis Foundation is registered as a tax-exempt nonprofit (EIN: 200291856). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Amyloidosis Foundation CEO make?
Amyloidosis Foundation's highest-compensated officer earns $1 annually. The organization reported $1.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Amyloidosis Foundation's spending goes to programs?
Amyloidosis Foundation directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Amyloidosis Foundation compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Amyloidosis Foundation is above average for NTEE category H25 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Amyloidosis Foundation located?
Amyloidosis Foundation is headquartered in Clarkston, Michigan and files with the IRS under EIN 200291856. It is classified under NTEE code H25.
How many years of IRS 990 filings does Amyloidosis Foundation have?
Amyloidosis Foundation has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.0M in total revenue.
Is the Amyloidosis Foundation a good charity?
Based on the provided data, the Amyloidosis Foundation appears to be a good charity. It demonstrates strong financial stability with growing assets, consistent IRS 990 filings, and notably, zero reported officer compensation, suggesting a highly efficient use of donor funds for its mission.
How has the organization's revenue trended over the last few years?
The organization's revenue has fluctuated in recent years, decreasing from $779,248 in 2021 to $535,162 in 2023, though it was $710,435 in 2022. This indicates some variability in annual income.
What is the financial stability of the Amyloidosis Foundation?
The Amyloidosis Foundation shows strong financial stability, consistently maintaining assets well over $1 million in recent years ($1,050,511 in 2023) and keeping liabilities very low (e.g., $4,622 in 2023). This indicates a healthy balance sheet and good financial management.
Filing History
IRS 990 filing history for Amyloidosis Foundation showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2010–2023), Amyloidosis Foundation's revenue has grown by 19.5%, moving from $448K to $535K. Total assets increased by 90.8% over the same period, from $551K to $1.1M. Total functional expenses rose by 82.9%, from $311K to $569K. In its most recent filing year (2023), Amyloidosis Foundation reported a deficit of $34K, with expenses exceeding revenue. The organization holds $5K in liabilities against $1.1M in assets (debt-to-asset ratio: 0.4%), resulting in net assets of $1.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $535K | $569K | $1.1M | $5K | — | — |
| 2022 | $710K | $598K | $1.1M | $21K | — | — |
| 2021 | $779K | $709K | $1.1M | $8K | — | View 990 |
| 2020 | $694K | $592K | $951K | $10K | — | — |
| 2019 | $738K | $684K | $757K | $16K | — | View 990 |
| 2018 | $661K | $625K | $665K | $3K | — | View 990 |
| 2017 | $844K | $810K | $690K | $5K | — | View 990 |
| 2016 | $704K | $730K | $612K | $2K | — | View 990 |
| 2015 | $579K | $828K | $662K | $50K | — | View 990 |
| 2014 | $861K | $509K | $855K | $12K | — | View 990 |
| 2013 | $457K | $358K | $493K | $2K | — | View 990 |
| 2012 | $426K | $465K | $393K | $24K | — | View 990 |
| 2011 | $335K | $449K | $408K | $0 | — | View 990 |
| 2010 | $448K | $311K | $551K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $535K, expenses of $569K, and assets of $1.1M (revenue -24.7% year-over-year).
- 2022: Revenue of $710K, expenses of $598K, and assets of $1.1M (revenue -8.8% year-over-year).
- 2021: Revenue of $779K, expenses of $709K, and assets of $1.1M (revenue +12.3% year-over-year).
- 2020: Revenue of $694K, expenses of $592K, and assets of $951K (revenue -5.9% year-over-year).
- 2019: Revenue of $738K, expenses of $684K, and assets of $757K (revenue +11.6% year-over-year).
- 2018: Revenue of $661K, expenses of $625K, and assets of $665K (revenue -21.7% year-over-year).
- 2017: Revenue of $844K, expenses of $810K, and assets of $690K (revenue +19.9% year-over-year).
- 2016: Revenue of $704K, expenses of $730K, and assets of $612K (revenue +21.6% year-over-year).
- 2015: Revenue of $579K, expenses of $828K, and assets of $662K (revenue -32.8% year-over-year).
- 2014: Revenue of $861K, expenses of $509K, and assets of $855K (revenue +88.6% year-over-year).
- 2013: Revenue of $457K, expenses of $358K, and assets of $493K (revenue +7.3% year-over-year).
- 2012: Revenue of $426K, expenses of $465K, and assets of $393K (revenue +27.2% year-over-year).
- 2011: Revenue of $335K, expenses of $449K, and assets of $408K (revenue -25.3% year-over-year).
- 2010: Revenue of $448K, expenses of $311K, and assets of $551K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Amyloidosis Foundation:
Data Sources and Methodology
This transparency report for Amyloidosis Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.